ClinicalTrials.Veeva

Menu

Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot Trial

K

Kyma Medical Technologies

Status

Withdrawn

Conditions

Congestive Heart Failure

Treatments

Device: uCor

Study type

Interventional

Funder types

Industry

Identifiers

NCT02700191
PCL-72-030

Details and patient eligibility

About

Subjects that are being treated at the Congestive Heart Failure clinic in Nazareth will be given the µ-Cor system to be added to their standard care, and randomized 1:1 to an interventional arm or a control arm.

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men or women 20-90 years old.
  • New York Heart Association (NYHA) class III-IV heart failure
  • Followed by the Congestive Heart Failure (CHF) clinic in Nazareth
  • Left ventricular ejection fraction <35%
  • Requiring treatment with >40mg/day of furosemide* orally or with repeated bolus or intravenous infusion of furosemide* (*or equivalent bumetanide or torasemide).

Exclusion criteria

  • Pregnancy
  • Subjects who have received a heart transplant.
  • Subjects who are unable or unwilling to follow the study requirements.
  • Patients with allergies or skin sensitivities to electrode hydrogel and/or acrylic based adhesive.
  • Patients with skin breakdown in areas on the chest where device and electrode placement is required

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

Control
No Intervention group
Description:
For subjects in the Control arm, the parameters measured by the (µ-Cor) µ-Cor system will not be analysed or made available to the investigator.
uCor
Experimental group
Description:
For subjects in the Interventional arm, all of the parameters measured by the (µ-Cor) µ-Cor system will be available to the investigator and will remain blinded to the subjects. The investigator will use µ-Cor information to aid in therapy adjustment decisions during the study period.
Treatment:
Device: uCor

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems